SCHEMBL6132641

SCHEMBL6132641

c1cnc(Cc2ccc3c(c2)OCO3)cn1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TAAR1 Q96RJ0 4/20 0.47
SLC6A4 P31645 3/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A3 Q01959 2/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23366762 0.80 L3MBTL1 (0.70) KDM4EALDH1A1L3MBTL1TAAR1SLC6A4
SCHEMBL11082938 0.76 TAAR1 (0.60) ALDH1A1TAAR1SLC6A4SLC6A2SLC6A3
SCHEMBL109195 0.76 TAAR1 (0.64) ALDH1A1TAAR1SLC6A4SLC6A2SLC6A3
SCHEMBL107308 0.74 TAAR1 (0.54) ALDH1A1L3MBTL1TAAR1SLC6A4SLC6A2
SCHEMBL108109 0.74 TAAR1 (0.62) ALDH1A1TAAR1SLC6A4SLC6A2SLC6A3
SCHEMBL4661709 0.73 TAAR1 (0.49) ALDH1A1L3MBTL1TAAR1SLC6A4SLC6A2
SCHEMBL4661711 0.73 L3MBTL1 (0.47) KDM4EALDH1A1L3MBTL1TAAR1SLC6A4
SCHEMBL3745991 0.73 TAAR1 (0.47) ALDH1A1L3MBTL1TAAR1SLC6A4SLC6A2
SCHEMBL7000283 0.71 TAAR1 (0.48) ALDH1A1L3MBTL1TAAR1SLC6A4SLC6A2
SCHEMBL28843776 0.71 TAAR1 (0.50) ALDH1A1TAAR1SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 KDM4E 2223/4885ALDH1A1 2608/4885L3MBTL1 4860/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 KDM4E 2408/4885ALDH1A1 1903/4885L3MBTL1 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.